Twitxy Saved

Yi Lin

@YiLinMDPhD

Professor; Mayo Clinic Comprehensive Cancer Center Deputy Director, Cancer Regenerative Biotherapeutics; Co-Chair, Experimental & Novel Therapeutics DG.
Mayo Clinic, Rochester, MN ow.ly/kCLJc Joined April 2013
261 Following 1.8K Followers 1.4K Posts

Latest posts 5

Yi Lin @YiLinMDPhD
#Myeloma Paper of the Day: CHARGE Prognostic Index (HRCAs, hyperferritinemia, anemia, early relapse (<18 mos from frontline), ECOG ≥2) & exposure to prior BCMA-directed tx) may identify RRMM pts at risk for early treatment failure w/ bispecifics: pubmed.ncbi.nlm.nih.gov/43024836/. #mmsm
View quoted post on X
1 replies 6 reposts 29 likes 1.4K views View on X
Yi Lin @YiLinMDPhD
Great analysis by @christoscha. Hope to share more analysis at #ASH26 on the effect of these mitigating strategies on immune profiles.
Myeloma Society Verified account @Myeloma_Society Sep 26
Severity of IEC-Parkinsonism was reduced, although overall incidence rate of delayed neurotoxicities & peak ALC expansion after cilta-cel unchanged w/ prophylactic cyclophosphamide, per observational study shared by Christoph Schaefers, MD #IMS26
View quoted post on X
Yi Lin @YiLinMDPhD
Excited to present preclinical data on #VV169 #InVivoCART Abstract Session 14 #IMS26. First-in-human trial is now open @MayoCancerCare true academic & pharma collab that will enable us to examine the mechanism of action in depth on trial @VyriadMN @JoselleCookMD @ESmithMDPhD
Myeloma Society Verified account @Myeloma_Society Sep 26
Abstract Sessions begin at 1:00 PM. Join us in Hall 5 for Abstract Session 13 or Lomond Auditorium for Abstract Session 14. #IMS26
View quoted post on X
0 replies 4 reposts 14 likes 1.4K views View on X